Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Search Results to Slide Tray Search:

"Evidence-based Practice Center"

Slides: 1–12 of 132
Add to tray Remove from tray

Clostridium difficile Infections: Diagnosis, Treatment, and Prevention

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: Agency for Healthcare Research and Quality | diagnosis | prevention | treatment | Clostridium difficile
Add to tray Remove from tray

Outline of this CME Activity

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: antibiotic treatment | diagnostic assays | prevention | recurrence | overview
Add to tray Remove from tray

Overview: Methods

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: analysis | data sources | literature | methods | overview
Add to tray Remove from tray

Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: acute coronary syndrome | comparative effectiveness review | distal embolization | percutaneous coronary intervention (PCI) | thrombus | Adjunctive devices
Add to tray Remove from tray

Outline of This CME Activity

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: outline | comparative effectiveness review | adjunctive devices | percutaneous coronary intervention | outcomes | adverse events
Add to tray Remove from tray

Rating the Strength of Evidence From the CER

Presentation: Adjunctive Devices for Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
Keywords: EPC | Evidence-based Practice Center | GRADE | PICOTS | applicability | comparative effectiveness review | strength of evidence
Add to tray Remove from tray

Analgesics for Osteoarthritis—An Update

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: analgesics | comparative effectiveness review | osteoarthritis | systematic review | background
Why Use Analytic Frameworks? To provide clinical, biological, or health services underpinnings for the mechanism of action. To clarify implicit assumptions. To identify logical flaws as key questions are developed. To provide a starting point for discussions with key informants. To identify distinct bodies of evidence to be included in the review.
Add to tray Remove from tray

Why Use Analytic Frameworks?

Presentation: Analytic Frameworks
Keywords: systematic review | Evidence-based Practice Center
Depicting Essential Components: An Example. Graphical chain of logic: Arrows - Linkages, Preventive service or treatment, Questions. Dotted lines – Associations. Rectangles - Intermediate outcomes, Rounded corners; Health states, Square corners. Curved arrows - Lead to ovals, Harms
Add to tray Remove from tray

Depicting Essential Components: An Example

Presentation: Analytic Frameworks
Keywords: analytic framework | components | Evidence-based Practice Center
This figure shows a blank portion of an analytic framework with a box with rounded edges connected to another box with rounded edges, which is then connected to a sharp-edged box. These represent two intermediate outcomes leading to a final health outcome. An arrow leads down from the figure to an oval shape, representing a potential harm. The framework also has an arrow leading directly form the first box to the final health outcomes box, indicating that there may also be a direct relationship.
Add to tray Remove from tray

Key Research Questions

Presentation: Analytic Frameworks
Keywords: key question | analytic framework | components | Evidence-based Practice Center
This presentation was prepared by Melissa L. McPheeters, Ph.D., M.P.H., a member of the Vanderbilt University Evidence-based Practice Center. The module is based on an update of chapter 2 in version 1.0 of the Methods Guide for Comparative Effectiveness Reviews (available at: http://www.effectivehealthcare.ahrq.gov/ehc/products/60/294/2009_0805_principles1.pdf).
Add to tray Remove from tray

Author

Presentation: Analytic Frameworks Quiz
Add to tray Remove from tray

Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults with Hypertension

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Pages: [1] 2 3 4 5 6 7 8 9 10 11 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Questions? | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364